MEDICINES CO's ticker is and the CUSIP is 584688AE5. A total of 41 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,604,000 | +20.5% | 2,157,000 | 0.0% | 0.68% | +6.8% |
| Q1 2019 | $2,161,000 | +16.2% | 2,157,000 | 0.0% | 0.64% | -0.8% |
| Q4 2018 | $1,860,000 | -37.1% | 2,157,000 | -21.6% | 0.64% | -9.1% |
| Q3 2018 | $2,959,000 | -25.1% | 2,750,000 | -15.4% | 0.70% | +66.0% |
| Q2 2018 | $3,953,000 | -42.9% | 3,250,000 | -45.8% | 0.42% | -16.4% |
| Q1 2018 | $6,920,000 | +8.9% | 6,000,000 | 0.0% | 0.51% | -2.1% |
| Q4 2017 | $6,357,000 | -16.3% | 6,000,000 | 0.0% | 0.52% | -32.0% |
| Q3 2017 | $7,591,000 | -3.0% | 6,000,000 | 0.0% | 0.76% | -9.3% |
| Q2 2017 | $7,823,000 | -17.5% | 6,000,000 | 0.0% | 0.84% | -7.6% |
| Q1 2017 | $9,477,000 | +31.4% | 6,000,000 | 0.0% | 0.91% | +32.3% |
| Q4 2016 | $7,212,000 | -7.2% | 6,000,000 | 0.0% | 0.69% | -13.5% |
| Q3 2016 | $7,769,000 | +9.3% | 6,000,000 | 0.0% | 0.79% | +35.5% |
| Q2 2016 | $7,109,000 | +525.8% | 6,000,000 | +500.0% | 0.59% | +544.0% |
| Q1 2016 | $1,136,000 | – | 1,000,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| City Financial Investment Co Ltd | 30,000,000 | $25,879,000 | 4.60% |
| Cheyne Capital Management (UK) LLP | 4,000,000 | $3,447,000 | 3.26% |
| DeepCurrents Investment Group LLC | 27,250,000 | $23,546,000 | 2.93% |
| Worth Venture Partners, LLC | 4,078,000 | $3,482,000 | 2.63% |
| SILVERBACK ASSET MANAGEMENT LLC | 11,000,000 | $9,515,000 | 1.76% |
| DLD Asset Management, LP | 27,500,000 | $23,994,000 | 1.64% |
| Myriad Asset Management Ltd. | 7,000,000 | $6,112,000 | 1.30% |
| Context Capital Management, LLC | 2,000,000 | $1,726,000 | 0.98% |
| Verition Fund Management LLC | 13,347,000 | $11,518,000 | 0.83% |
| Castle Creek Arbitrage, LLC | 2,157,000 | $1,860,000 | 0.64% |